Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Schizo-EPICOG

Financiado

Cerrado

Inflammatory processes underlying cognitive deficits in schizophrenia epigeneti...

Inflammatory processes underlying cognitive deficits in schizophrenia epigenetic mechanisms and pharmacological regulation "Cognitive deficits represent nuclear symptoms of schizophrenia and are considered prognostic factors of the disease. Moreover, they are resistant to the currently available treatments and it is clinically suspected that atypical... ver más

26/01/2021

UPV

158K€

Presupuesto del proyecto: 158K€

Líder del proyecto

UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNI... No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 45

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-01-26

MSCA-IF-2016: Individual Fellowships

I+D

Cerrada hace 8 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UPV

158.12K€ | Lider

Proyectos interesantes

PID2019-106404RB-I00

Medical Technol...

Applied Physics

131K€ Cerrado

BFU2009-10109

Medical Technol...

Applied Physics

145K€ Cerrado

SCHIZOAMINE

Medical Technol...

Applied Physics

129K€ Cerrado

BFU2008-02950-C03-02

Medical Technol...

Neuroscience

42K€ Cerrado

PID2020-119428RB-I00

Medical Technol...

Psychiatry

198K€ Cerrado

BFU2008-02950-C03-01

Medical Technol...

Neuroscience

236K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 47 meses Fecha Inicio: 2017-02-24
Fecha Fin: 2021-01-26

Líder del proyecto

UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNI... No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 45

Presupuesto del proyecto 158K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Cognitive deficits represent nuclear symptoms of schizophrenia and are considered prognostic factors of the disease. Moreover, they are resistant to the currently available treatments and it is clinically suspected that atypical antipsychotics might worsen cognitive conditions of schizophrenic patients. Preliminary data indicate the involvement of epigenetic regulation of histone deacetylases (HDACs) in this effect and the possibility of neuroinflammmatory activity as the inductor mechanism. In the etiopathogenesis of schizophrenia a double-hit phenomenon has been suggested. Thus, a prenatal priming event that would induce vulnerability is followed by a second stressful hit in peripuberty. Physio- and psychopathology could emerge from these mechanisms through neuroinflammatory hyperactivity. The aim of the present project is to study the relationship between cognitive deficits and neuroinflammatory activity in a traslational ""double hit"" mouse model based on the maternal inmmune activation during gestation followed by social isolation at puberty. In this animal model will be evaluated: 1) Gene and protein expression of inflammatory signalling proteins, HDACs and the status of histone acetylation; 2) Cognitive and psychotic status by means of validated behavioural tests; 3) Modulation of cognitive responses by chronic treatment with the antipsychotic clozapine, the HDAC inhibitor SAHA and the inflammatory activity inhibitor minocycline. Cognitive responses will be related to neuroinflammatory alterations at molecular level. The findings in the animal model will be compared with those obtained in the study of neuroinflammation markers, HDACs expression and histone acetylation status in postmortem human prefrontal cortex of subjects with schizophrenia under antipsychotic treatment or drug-free conditions and matched controls. In these subjects the possibility of an excess of inflammatory activity associated to antipsychotic treatment will be analyzed."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores